Clinical Trials List
Protocol NumberAMN002/ ALLG MM18
2017-08-15 - 2022-08-15
Phase II
Not yet recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- MING YAO Division of Hematology & Oncology
- Chien-Yuan Chen Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8-10 participants
-
Global
100 participants
